Universe Pharmaceuticals Net Worth
Universe Pharmaceuticals Net Worth Breakdown | UPC |
Universe Pharmaceuticals Net Worth Analysis
Universe Pharmaceuticals' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Universe Pharmaceuticals' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Universe Pharmaceuticals' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Universe Pharmaceuticals' net worth analysis. One common approach is to calculate Universe Pharmaceuticals' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Universe Pharmaceuticals' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Universe Pharmaceuticals' net worth. This approach calculates the present value of Universe Pharmaceuticals' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Universe Pharmaceuticals' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Universe Pharmaceuticals' net worth. This involves comparing Universe Pharmaceuticals' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Universe Pharmaceuticals' net worth relative to its peers.
To determine if Universe Pharmaceuticals is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Universe Pharmaceuticals' net worth research are outlined below:
| Universe Pharmaceuticals generated a negative expected return over the last 90 days | |
| Universe Pharmaceuticals has high historical volatility and very poor performance | |
| Universe Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Universe Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the last year's revenue of 32.31 M. Reported Net Loss for the year was (6.16 M) with profit before taxes, overhead, and interest of 7.56 M. | |
| Latest headline from news.google.com: Universe Pharmaceuticals stock plunges to 52-week low of 0.1 - Investing.com |
Universe Pharmaceuticals uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Universe Pharmaceuticals. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Universe Pharmaceuticals' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 9th of February 2024 Upcoming Quarterly Report | View | |
| 30th of September 2023 Next Fiscal Quarter End | View |
Know Universe Pharmaceuticals' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Universe Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Universe Pharmaceuticals backward and forwards among themselves. Universe Pharmaceuticals' institutional investor refers to the entity that pools money to purchase Universe Pharmaceuticals' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Sabby Management Llc | 2024-12-31 | 333.4 K | Anson Funds Management Lp | 2024-12-31 | 230.4 K | Virtu Financial Llc | 2024-09-30 | 16.6 K | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 65.0 | Millennium Management Llc | 2024-12-31 | 0.0 | Renaissance Technologies Corp | 2024-12-31 | 0.0 | Mml Investors Services Inc | 2024-12-31 | 0.0 | Xtx Topco Ltd | 2024-12-31 | 0.0 | Quadrature Capital Llp | 2024-12-31 | 0.0 | Two Sigma Securities, Llc | 2024-12-31 | 0.0 | Ubs Group Ag | 2024-12-31 | 0.0 |
Follow Universe Pharmaceuticals' market capitalization trends
The company currently falls under 'Nano-Cap' category with a total capitalization of 33.53 K.Market Cap |
|
Project Universe Pharmaceuticals' profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.12) | (0.13) | |
| Return On Capital Employed | (0.10) | (0.10) | |
| Return On Assets | (0.12) | (0.13) | |
| Return On Equity | (0.18) | (0.17) |
When accessing Universe Pharmaceuticals' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Universe Pharmaceuticals' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Universe Pharmaceuticals' profitability and make more informed investment decisions.
Please note, the presentation of Universe Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Universe Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Universe Pharmaceuticals' management manipulating its earnings.
Evaluate Universe Pharmaceuticals' management efficiency
Universe Pharmaceuticals has Return on Asset of (0.0565) % which means that on every $100 spent on assets, it lost $0.0565. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.5022) %, meaning that it generated no profit with money invested by stockholders. Universe Pharmaceuticals' management efficiency ratios could be used to measure how well Universe Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of March 23, 2025, Return On Tangible Assets is expected to decline to -0.13. The current year's Return On Capital Employed is expected to grow to -0.1. At present, Universe Pharmaceuticals' Intangible Assets are projected to decrease significantly based on the last few years of reporting. The current year's Intangibles To Total Assets is expected to grow to 0.01, whereas Total Assets are forecasted to decline to about 47.2 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 9.82 | 6.59 | |
| Tangible Book Value Per Share | 9.78 | 6.56 | |
| Enterprise Value Over EBITDA | (18.55) | (17.62) | |
| Price Book Value Ratio | 1.50 | 1.43 | |
| Enterprise Value Multiple | (18.55) | (17.62) | |
| Price Fair Value | 1.50 | 1.43 |
Effective leadership at Universe Pharmaceuticals drives its competitive edge in the market. Our analysis focuses on how this translates to financial performance and stock value.
Enterprise Value Revenue 0.0174 | Revenue | Quarterly Revenue Growth (0.30) | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Universe Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Universe Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Universe Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
White John V over a month ago Acquisition by White John V of 1222 shares of Universe Pharmaceuticals subject to Rule 16b-3 | ||
White John V over six months ago Acquisition by White John V of 10050 shares of Universe Pharmaceuticals at 19.1667 subject to Rule 16b-3 | ||
Trippeer Richard A Jr over six months ago Acquisition by Trippeer Richard A Jr of 6200 shares of Universe Pharmaceuticals at 33.48 subject to Rule 16b-3 | ||
Moore Jackson W over six months ago Acquisition by Moore Jackson W of 308212 shares of Universe Pharmaceuticals at 29.22 subject to Rule 16b-3 | ||
Moore Jackson W over six months ago Acquisition by Moore Jackson W of 13100 shares of Universe Pharmaceuticals subject to Rule 16b-3 |
Universe Pharmaceuticals Earnings per Share Projection vs Actual
When determining whether Universe Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Universe Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Universe Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Universe Pharmaceuticals Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Universe Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade Universe Stock refer to our How to Trade Universe Stock guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Universe Pharmaceuticals. If investors know Universe will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Universe Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.82) | Earnings Share -3.1 K | Revenue Per Share | Quarterly Revenue Growth (0.30) | Return On Assets |
The market value of Universe Pharmaceuticals is measured differently than its book value, which is the value of Universe that is recorded on the company's balance sheet. Investors also form their own opinion of Universe Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Universe Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Universe Pharmaceuticals' market value can be influenced by many factors that don't directly affect Universe Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Universe Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Universe Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Universe Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.